StockData
First Tracks Biotherapeutics, Inc. logo

First Tracks Biotherapeutics, Inc. (TRAX) stock

TRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026
$43.57−2.99 (-6.42%)

Close on Nov 17, 2026Market cap $1.56BP/E –Yield –

First Tracks Biotherapeutics total assets

Total assets on the balance sheet at the end of each period.

First Tracks Biotherapeutics's total assets was $170.46M at Sep 30, 2026. For fiscal 2025 it was $330.55M.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$330.55M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$170.46M–
Q2 FY2026Jun 30, 2026$183.14M–
Q1 FY2026Mar 31, 2026$290.58M–
Q4 FY2025Dec 31, 2025$330.55M–

More First Tracks Biotherapeutics figures

See a number that looks wrong?